Paid Clinical Trials Oklahoma
Discover 433 paid clinical trials in Oklahoma. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
LetrozoleLetrozole in Uterine Leiomyosarcoma
Sponsor:
GOG Foundation
Location:
Code:
NCT05649956
Conditions
Uterine Leiomyosarcoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Letrozole
FT825/ONO-8250 & Monoclonal AntibodiesFT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, with or Without Monoclonal Antibodies in Advanced Solid Tumors
Sponsor:
Fate Therapeutics
Location:
Code:
NCT06241456
Conditions
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FT825
Fludarabine
Cyclophosphamide
Bendamustine
Docetaxel
NutritionStrength and Muscle Related Outcomes for Nutrition and Lung Function in CF
Sponsor:
Jaeb Center for Health Research
Location:
Code:
NCT05639556
Conditions
Cystic Fibrosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BMI and lean mass index from DXA
Anthropometric Measurements
Hand-grip strength
Six-minute walk Test
Sit-to-Stand Test
Therapeutic OmegasTherapeutic Omegas for Triglyceride Suppression
Sponsor:
University of Colorado, Denver
Location:
Code:
NCT04349475
Conditions
Pregnancy
Eligibility Criteria
Sex: All
Age: 0 - 39
Healthy Volunteers: Accepted
Interventions
Intervention Omega 3 Supplementation
Control Safflower Oil
MicroRNAsIdentify microRNAs in Cachexia in Pancreatic Carcinoma
Sponsor:
University of Oklahoma
Location:
Code:
NCT05275075
Conditions
Resectable Pancreatic Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pancreatic cancer microRNA and messenger RNA expression.
LutikizumabA Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis
Sponsor:
AbbVie
Location:
Code:
NCT06257875
Conditions
Ulcerative Colitis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Lutikizumab Matching Placebo
Adalimumab Matching Placebo
Lutikizumab
Adalimumab
GC5107Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
Sponsor:
Green Cross Corporation
Location:
Code:
NCT04565015
Conditions
Primary Immune Deficiency
Eligibility Criteria
Sex: All
Age: 2 - 16
Healthy Volunteers: Not accepted
Interventions
GC5107
Observational StudyADVENT Post Approval Study
Sponsor:
Boston Scientific Corporation
Location:
Code:
NCT06431815
Conditions
Paroxysmal Atrial Fibrillation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FARAPULSE™ Pulsed Field Ablation System
CenerimodA Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus
Sponsor:
Idorsia Pharmaceuticals Ltd.
Location:
Code:
NCT05648500
Conditions
Lupus Erythematosus, Systemic
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Cenerimod
Placebo